Hallal et al. further demonstrated that urine-derived EVs from IDH wild-type GBM patients carried molecular signatures indicative of glioblastoma, representing a promising, fully non-invasive approach for tumor detection and monitoring [24]. Here, IDH1 is linked to glioblastoma.